LISTEN NOW | The United States, once a beacon of medical innovation, now languishes under the suffocating grip of an utterly dysfunctional drug trial process, crippled by the Food & Drug Administration’s (FDA) labyrinthine regulations and Big Pharma’s insatiable greed. While the world advances, offering hope to millions suffering from debilitating diseases, the US medical establishment remains mired in bureaucratic quicksand, denying patients access to transformative treatments like adult stem cell-derived exosome therapies. This is not just incompetence—it’s a moral failing, a betrayal of the sick and vulnerable who are left to deteriorate while the FDA dithers and Big Pharma counts its profits.